NPAS2 and colorectal carcinoma: The marked escalation from 2016 to 2021 reflected two pivotal developments: First, large-scale genomic analyses found that circadian genes like PER1, PER3, and NPAS2 were frequently changed and out of whack in CRC (22, 23).